ProcessIntermediate
What is the recommended dosage and administration route for abaloparatide in postmenopausal women with osteoporosis?
The recommended dosage of abaloparatide for postmenopausal women with osteoporosis at high risk for fracture is 80 mcg administered subcutaneously once daily.
Key points
- Dosage: 80 mcg once daily
- Administration route: Subcutaneous
- Indicated for postmenopausal women with osteoporosis at high fracture risk
- Inspect solution for particulate matter before use
- Rotate injection sites daily
Related questions
- What are the contraindications for abacavir as listed in Mosby's 2021 Nursing Drug Reference?
- What are the nursing considerations for administering clotrimazole for vaginal candidiasis?
- What are the uses of carbonic anhydrase inhibitors in ophthalmic treatment?
- What is the dosage schedule for the anthrax vaccine BioThrax for pre-exposure prophylaxis in adults?
- How is the Japanese encephalitis virus vaccine administered to adults and children over 3 years?
- How should adenosine be administered for converting paroxysmal supraventricular tachycardia in adults and children over 50 kg?
Mosbys 2021 Nursing Drug Reference by Linda Skidmore-Roth
Unknown
THIRTY-FOURTH EDITION · Elsevier Inc.